Method development and validation of LC–MS/MS‐based assay for the simultaneous quantitation of trastuzumab and pertuzumab in cynomolgus monkey serum and its application in pharmacokinetic study-Reference-Cited by-同舟云学术

Method development and validation of LC–MS/MS‐based assay for the simultaneous quantitation of trastuzumab and pertuzumab in cynomolgus monkey serum and its application in pharmacokinetic study

Published:2020-09-28 Issue:12 Volume:34 Page:
ISSN:0269-3879
Container-title:Biomedical Chromatography
language:en
Short-container-title:Biomedical Chromatography

Author:

Gui Luo‐lan¹²³^ORCID,Li Li²³,Dong Li‐hou²³,Xiang Shen‐si²,Zhai Jian‐ping¹²³,Ge Zhi‐qiang¹,Song Hai‐feng²

Affiliation:

1. School of Chemical Engineering Tianjin University Tianjin China

2. State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing) Beijing Institute of Lifeomics Beijing China

3. Beijing United‐Power Pharma Tech Co., Ltd. Beijing China

Publisher

Wiley

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,General Medicine,Biochemistry,Analytical Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bmc.4903

Reference22 articles.

1. 2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 2 – hybrid LBA/LCMS and input from regulatory agencies)

2. A Phase I Study of the Safety and Pharmacokinetics of the Combination of Pertuzumab (rhuMab 2C4) and Capecitabine in Patients with Advanced Solid Tumors;Albanell J.;Clinical Cancer Research,2008

3. LC‐MS/MS‐based monitoring of in vivo protein biotransformation: quantitative determination of trastuzumab and its deamidation products in human plasma;Bults P.;Analytical Chemistry,2015

4. Guidance for industry bioanalytical method validation. [FDA web site] Available at:https://www.fda.gov/downloads/drugs/guidances/ucm070107.pdf (2018). (Accessed 18 February 2019)

5. Conjugated critical reagent characterization for ligand-binding assays: using MALDI-TOF-MS as an orthogonal tool to assess assay performance

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integration of protein L-immobilized epoxy magnetic bead capture with LC-MS/MS for therapeutic monoclonal antibody quantification in serum;Analytical Methods;2024

2. Simultaneous quantification of co-administered trastuzumab and pertuzumab in serum based on nano-surface and molecular-orientation limited (nSMOL) proteolysis;RSC Advances;2024

3. Development of an efficient mAb quantification assay by LC-MS/MS using rapid on-bead digestion;Analytica Chimica Acta;2022-02

4. Analytical and pharmacological consequences of the in vivo deamidation of trastuzumab and pertuzumab;Analytical and Bioanalytical Chemistry;2022-01-10

5. Development of a reversed‐phase high‐performance liquid chromatographic method for the determination of propranolol in different skin layers;Biomedical Chromatography;2020-10-16